Who invested in Lumicell

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$30Mraised across 2 rounds since 2014, from 2 sources

$1.6MVenture$29MSeries C

Latest round: Series C, $29MDec 2017
Step-upi: 18.4×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201520162017

$1.6MVenture$29MSeries C

First round: Venture, $1.6M
Biggest round: $29M
Between rounds: 3.6 years

The rounds

Dec 2017
Series C$29M2 new
- Launch Capital
- BlueIO
Reported by FinSMEsSEC filing: $21M sold, first sale Jun 2017
Apr 2014
Venture$1.6M
No investor was named in the report.
From a historical funding recordSEC filing: $1.6M sold, first sale Dec 2013

Founders and team

From Lumicell's own website: 1 founder, 3 on the team.

W. David LeeFounder, Lumicell

Cosimo FiorenzaVice President & General Counsel
Kate SmithVice President, Clinical Affairs & Pharmacovigilance
Anika TherapeuticsBoard of Observers

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2014Series C2017

Launch Capital

BlueIO

Everyone who backed them

Launch CapitalFamily office1round

BlueIOPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Lumicell as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.